Treatment of a genetic brain disease by CNS-wide microglia replacement.
Shibuya, Y; Kumar, KK; Mader, MM D; Yoo, Y; Ayala, LA; Zhou, M; Mohr, MA; Neumayer, G; Kumar, I; Yamamoto, R; et al.
Science Translational Medicine.
2022;
14.
Analysis of the Biomarkers for Neurodegenerative Diseases in Aged Progranulin Deficient Mice.
Zhao, X; Hasan, S; Liou, B; Lin, Y; Sun, Y; Liu, C.
International Journal of Molecular Sciences.
2022;
23.
Progranulin associates with Rab2 and is involved in autophagosome-lysosome fusion in Gaucher disease.
Zhao, X; Liberti, R; Jian, J; Fu, W; Hettinghouse, A; Sun, Y; Liu, CJ.
Journal of Molecular Medicine.
2021;
99:1639-1654.
Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher Disease.
Peng, Y; Liou, B; Lin, Y; Fannin, V; Zhang, W; Feldman, RA; Setchell, KD R; Grabowski, GA; Sun, Y.
Cells.
2021;
10.
Optimization of Eliglustat-Based Glucosylceramide Synthase Inhibitors as Substrate Reduction Therapy for Gaucher Disease Type 3.
Wilson, MW; Shu, L; Hinkovska-Galcheva, V; Jin, Y; Rajeswaran, W; Abe, A; Zhao, T; Luo, R; Wang, L; Wen, B; et al.
ACS Chemical Neuroscience.
2020;
11:3464-3473.
Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles.
Davis, HW; Vallabhapurapu, SD; Chu, Z; Wyder, MA; Greis, KD; Fannin, V; Sun, Y; Desai, PB; Pak, KY; Gray, BD; et al.
Cells.
2020;
9.
Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease.
Sun, Y; Liou, B; Chu, Z; Fannin, V; Blackwood, R; Peng, Y; Grabowski, GA; Davis, HW; Qi, X.
EBioMedicine.
2020;
55.
Lead Optimization of Benzoxazolone Carboxamides as Orally Bioavailable and CNS Penetrant Acid Ceramidase Inhibitors.
Di Martino, S; Tardia, P; Cilibrasi, V; Caputo, S; Mazzonna, M; Russo, D; Penna, I; Realini, N; Margaroli, N; Migliore, M; et al.
Journal of Medicinal Chemistry.
2020;
63:3634-3664.
One-off liver directed AAV gene therapy achieves long term uptake of acid beta-glucocerebrosidase by macrophages of affected tissues in Gaucher disease.
Miranda, CJ; Chisari, E; Northcott, N; Pandya, J; Liou, B; Fannin, V; Blackwood, R; Dane, A; Kia, A; Canavese, M; et al.
Molecular Genetics and Metabolism.
2020;
129.
The therapeutic effect of progranulin derived Pcgin on neuronopathic Gaucher disease.
Zhao, X; Hettinghouse, A; Liou, B; Fannin, V; Blackwood, R; Liu, C; Sun, Y.
Molecular Genetics and Metabolism.
2020;
129:s165-s166.